WAYNE, Pa.--(BUSINESS WIRE)--Jan. 23, 2015--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care, urology and surgery, will showcase its Arrow®
brand GPSCath® interventional product platform at the Leipzig
Interventional Course (LINC) to be held in Leipzig, Germany on January
27 - 30, 2015.
During the event, the Company will highlight the Arrow® GPSCath® Balloon
Dilatation Catheter, which features the VisioValve™ technology. The
GPSCath® Catheter is a specialty two-in-one device that is indicated for
percutaneous transluminal angioplasty (PTA) in the peripheral
vasculature, including iliac, femoral, popliteal, infrapopliteal and
renal arteries.
Teleflex is pleased to present a live case transmission with Dr. Ralf
Langhoff from St. Gertrauden Krankenhaus, Berlin, Germany. The live
case, entitled “A comprehensive approach to diabetic patient treatment,”
can be attended at the GLOBAL EXPERT EXCHANGE FORUM, room 5, on Tuesday,
January 27 at 13:46h – 14:08h.
Additionally, two Satellite Symposiums are scheduled. The first
symposium entitled “BTK Complex: Using Arrow® GPSCath® Catheter to
protect wire placement, reduce fluoroscopy while minimising contrast,”
is presented by Dr. Michael Lichtenberg from Klinikum Arnsberg, Germany
on Thursday, January 29, at 08:00h-09:30h in the Main Arena 1. The
second symposium is presented by Prof. Miloslav Roček (Prague, Czech
Republic) and is entitled “BTK Strategies: New way in treating crural
arteries using Arrow® GPSCath® Catheter with VisioValve™ technology to
reduce contrast and procedural time.” It will be held on Thursday,
January 29, at 13:30h-16.30h, at Technical Forum, room 3.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care, urology and surgery. Our mission
is to provide solutions that enable healthcare providers to improve
outcomes and enhance patient and provider safety. Headquartered in
Wayne, PA, Teleflex employs approximately 11,500 people worldwide and
serves healthcare providers in more than 150 countries. Additional
information about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, GPSCath and VisioValve are trademarks or registered (in
the U.S. and/or other countries) trademarks of Teleflex Incorporated or
its affiliates.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com
www.teleflex.com